McKesson Releases Fiscal Year 2026 Impact Report

IRVING, TX, July 13, 2026—McKesson Corporationtoday published itsFiscal Year 2026 (FY26) Impact Report, capturing how the company is actively turning purpose into action across healthcare. Covering the reporting period from April 1, 2025, through March 31, 2026, the comprehensive report outlines key milestones achieved across McKesson’s four impact pillars: Our People, Our Partners, Our Community and Our Planet.

“At McKesson, impact is at the heart of our strategy and embedded in how we operate every day,” said Nimesh Jhaveri, R.Ph., Executive Vice President and Chief Impact Officer. “This year’s report reflects our progress in strengthening healthcare for the providers, patients and communities we serve today, while building the capabilities needed for tomorrow. As healthcare grows more complex, our focus remains simple: Advancing Health Outcomes for All®.”

Strategic Impact Pillars & Key Milestones

• Our PeopleMcKesson helped prepare itsover 43,000workforce for a human-led AI future with amore than 95%digital learning participation rate among wired employees.The company also introduced its new McKesson Leadership Prescription uniting its I²CARE values and LEADRx behaviors to help employees lead with purpose, move with speed and deliver at the level customers and patients depend on — today and into the future.

• Our PartnersPatients count on safe, reliable access to critical medications — and through an automated, digitally connected distribution network, McKesson delivers on that promise by distributing one-third of America’s medicines with more than 99% inventory and order accuracy.Through The US Oncology Network, McKesson is helping reimagine how cancer care is delivered, advancing a community-based model that expands access to high-quality, patient-centered care close to home. Supporting approximately 3,300 independent oncology providers across The US Oncology Network, McKesson enables practices to deliver innovative therapies, participate in clinical trials and navigate increasing treatment complexity — advancing care for patients.

• Our CommunityIn FY26, McKesson and the McKesson Foundation contributed over $17 million to external organizations and initiatives that help make a meaningful difference in communities.Additionally, McKesson employees logged nearly 40,000 volunteer hours with over 700 charities across the U.S. and Canada. In recognition of these efforts, the McKesson Foundation awarded hundreds of individual and team grants, providing substantial charitable funding in support of employee-driven impact.

• Our PlanetThrough its leadership in the National Academy of Medicine’s Climate Collaborative and collaboration with Guidehouse to develop the Supplier Leadership on Climate Transition program, McKesson is helping accelerate emissions reduction and build a more sustainable, climate-resilient healthcare supply chain.

• McKesson helped prepare itsover 43,000workforce for a human-led AI future with amore than 95%digital learning participation rate among wired employees.

• The company also introduced its new McKesson Leadership Prescription uniting its I²CARE values and LEADRx behaviors to help employees lead with purpose, move with speed and deliver at the level customers and patients depend on — today and into the future.

• Patients count on safe, reliable access to critical medications — and through an automated, digitally connected distribution network, McKesson delivers on that promise by distributing one-third of America’s medicines with more than 99% inventory and order accuracy.

• Through The US Oncology Network, McKesson is helping reimagine how cancer care is delivered, advancing a community-based model that expands access to high-quality, patient-centered care close to home. Supporting approximately 3,300 independent oncology providers across The US Oncology Network, McKesson enables practices to deliver innovative therapies, participate in clinical trials and navigate increasing treatment complexity — advancing care for patients.

• In FY26, McKesson and the McKesson Foundation contributed over $17 million to external organizations and initiatives that help make a meaningful difference in communities.

• Additionally, McKesson employees logged nearly 40,000 volunteer hours with over 700 charities across the U.S. and Canada. In recognition of these efforts, the McKesson Foundation awarded hundreds of individual and team grants, providing substantial charitable funding in support of employee-driven impact.

• Through its leadership in the National Academy of Medicine’s Climate Collaborative and collaboration with Guidehouse to develop the Supplier Leadership on Climate Transition program, McKesson is helping accelerate emissions reduction and build a more sustainable, climate-resilient healthcare supply chain.

For more detailed data tables, sustainability indexes and comprehensive narrative case studies aligned with the Global Reporting Initiative (GRI), Sustainability Accounting Standards Board (SASB) and the Task Force on Climate-related Financial Disclosures (TCFD) frameworks, pleasedownload the complete publication.

McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare atMcKesson.comand readStories & Insights.

Melissa SeekelyCommunicationsMelissa.Seekely@McKesson.com

• McKesson Corporation Announces First Quarter Fiscal 2027 Earnings Release Date

• McKesson Closes Strategic Investment with Apollo Funds for Minority Interest in Medical-Surgical Solutions

• McKesson Reports Fiscal 2026 Fourth Quarter and Full Year Results, Provides Fiscal 2027 Guidance, and Reaffirms Long-Term Financial Growth Targets

• McKesson Corporation Declares Quarterly Dividend

• McKesson Signs Agreement with Apollo Funds for Strategic Minority Interest in Medical-Surgical Solutions

• Corporate